glp 1 and chronic kidney disease GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes Glucagon-like Peptide-1 Receptor Agonists: New

Most GLP-1 medications (semaglutide, liraglutide, dulaglutide) do not directly reduce contraceptive efficacy

Patients with diabetes who took semaglutide were more than four times more likely to develop NAION than those on other medications

Mobile IV therapy is a form of intravenous treatment where a licensed clinician (usually a registered nurse under medical oversight) comes to your home, office, hotel, or event

This timeframe was selected following the FDAs 2017 approval of the most recent GLP-1RA for diabetes management 37

Injection sites must also be rotated to prevent irritation and lipodystrophy, which causes fatty lumps on the body